Operator: Good morning, and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen only-mode.
Operator: Good morning, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Operator: Welcome to the Acorda Therapeutics Fourth Quarter and Year-End 2022 Financial and Business Update. Please be advised that this call is being recorded at the company s request.
Basilea Pharmaceutica AG (OTC:BPMUF) Q2 2022 Earnings Conference Call August 16, 2022, 10:00 ET Company Participants David Veitch - CEO Adesh Kaul - CFO Marc Engelhardt - Chief Medical.